Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Pancreatic Neoplasms 2Surgical Wound Infection 1Neutropenia 1Neoplasms 1Hematologic Neoplasms 1Febrile Neutropenia 1Dysbiosis 1

Interventions

Meropenem 6Ceftazidime 5Vancomycin 4Ciprofloxacin 3Cefepime 3Teicoplanin 2Levofloxacin 2Amikacin 2ceftolozane, tazobactam drug combination 1Vaccination 1Tazobactam 1Simvastatin 1Pneumococcal Vaccines 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Ofloxacin 1Micafungin 1Metronidazole 1Injections 1Filgrastim 1Cilastatin, Imipenem Drug Combination 1Anti-Bacterial Agents 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Febrile Neutropenia × Metronidazole × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡